New Jenner Vaccine Programmes
Outbreak Pathogens: Zika, Chikungunya, Rift Valley Fever and MERS
The vulnerability of the world to infectious disease, highlighted by the 2014 Ebola virus disease outbreak in West Africa, has led to major discussions between many authorities and expert groups regarding which vaccines to develop in order to avoid more outbreaks. The World Health Organisation, the UK Vaccines Research and Development Network, the recently formed Coalition for Epidemic Preparedness Innovations, and Science Magazine have all developed priority lists of target diseases for vaccine design and development.
Common to these lists are ten diseases, all of which the Jenner Institute is developing candidate vaccines for, using its proprietary simian adenoviral vectors and the specialist expertise of its viral vector core facility.
Four of these vectored vaccine candidates will now be progressing rapidly to GMP manufacture and clinical trials with UK government funding support, as described here:
Chikungunya Virus Vaccine Programme
Rift Valley Fever Vaccine Programme